Evaxion Biotech A/S Annual Research And Development Expense in USD from 2018 to 2023

Taxonomy & unit
ifrs-full: USD
Summary
Evaxion Biotech A/S annual/quarterly Research And Development Expense history and growth rate from 2018 to 2023.
  • Evaxion Biotech A/S Research And Development Expense for the quarter ending June 30, 2023 was $2.94M, a 28.6% decline year-over-year.
  • Evaxion Biotech A/S annual Research And Development Expense for 2023 was $11.9M, a 30.1% decline from 2022.
  • Evaxion Biotech A/S annual Research And Development Expense for 2022 was $17.1M, a 12.9% decline from 2021.
  • Evaxion Biotech A/S annual Research And Development Expense for 2021 was $19.6M, a 79.6% increase from 2020.
Research And Development Expense, Trailing 12 Months (USD)
Research And Development Expense, Annual (USD)
Research And Development Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $11.9M -$5.14M -30.1% Jan 1, 2023 Dec 31, 2023 20-F 2024-03-26
2022 $17.1M -$2.53M -12.9% Jan 1, 2022 Dec 31, 2022 20-F 2024-03-26
2021 $19.6M +$8.68M +79.6% Jan 1, 2021 Dec 31, 2021 20-F 2024-03-26
2020 $10.9M +$2.69M +32.7% Jan 1, 2020 Dec 31, 2020 20-F 2023-04-28
2019 $8.22M +$4.49M +120% Jan 1, 2019 Dec 31, 2019 20-F 2022-03-31
2018 $3.73M Jan 1, 2018 Dec 31, 2018 20-F 2021-04-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.